{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: CCNU was administered per os ( PO ) at a targeted dosage of 60 mg / m ( 2 ) body surface area on day 0 , CTX was administered PO at a targeted dosage of 250 mg / m ( 2 ) divided over days 0 through 4 , and all dogs received prophylactic antibiotics .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the paragraph |\n\nThe paragraph is discussing the administration of CCNU and CTX to dogs for treatment, but it does not mention any specific diseases or conditions."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the paragraph |\n\nThe paragraph is discussing the administration of drugs (CCNU and CTX) to dogs for treatment, but it does not mention any specific diseases or conditions."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: CCNU was administered per os ( PO ) at a targeted dosage of 60 mg / m ( 2 ) body surface area on day 0 , CTX was administered PO at a targeted dosage of 250 mg / m ( 2 ) divided over days 0 through 4 , and all dogs received prophylactic antibiotics .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| CCNU (N-[4-methyl-2-pyrimidinyl]-N'-nitrosourea) |\n| CTX (Cyclophosphamide) |\n\nExplanation:\nCCNU and CTX are the specific chemical entities mentioned in the paragraph. The dosages and administration routes provided help to identify these entities precisely."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| CCNU (N-[4-methyl-2-pyrimidinyl]-N'-nitrosourea) |\n| CTX (Cyclophosphamide) |\n\nExplanation:\nCCNU and CTX are the only entities in the paragraph that clearly refer to specific chemical substances. The other entities, such as \"per os (PO)\" and \"body surface area,\" are not chemicals but rather administration routes and measurements."}
  ]
}